Abeona Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABEO and other ETFs, options, and stocks.About ABEO
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB).
CEOVishwas Seshadri
CEOVishwas Seshadri
Employees136
Employees136
HeadquartersCleveland, Ohio
HeadquartersCleveland, Ohio
Founded1974
Founded1974
Employees136
Employees136
ABEO Key Statistics
Market cap276.11M
Market cap276.11M
Price-Earnings ratio4.48
Price-Earnings ratio4.48
Dividend yield—
Dividend yield—
Average volume941.61K
Average volume941.61K
High today$5.17
High today$5.17
Low today$5.02
Low today$5.02
Open price$5.11
Open price$5.11
Volume1.66M
Volume1.66M
52 Week high$7.54
52 Week high$7.54
52 Week low$3.93
52 Week low$3.93
Stock Snapshot
The current Abeona Therapeutics(ABEO) stock price is $5.09, with a market capitalization of 276.11M. The stock trades at a price-to-earnings (P/E) ratio of 4.48.
As of 2026-01-08, Abeona Therapeutics(ABEO) stock has fluctuated between $5.02 and $5.17. The current price stands at $5.09, placing the stock +1.4% above today's low and -1.5% off the high.
The Abeona Therapeutics(ABEO)'s current trading volume is 1.66M, compared to an average daily volume of 941.61K.
In the last year, Abeona Therapeutics(ABEO) shares hit a 52-week high of $7.54 and a 52-week low of $3.93.
In the last year, Abeona Therapeutics(ABEO) shares hit a 52-week high of $7.54 and a 52-week low of $3.93.
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own ABEO. This list is generated using Robinhood data, and it’s not a recommendation.